¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇÑ°¨¿°ÇÐȸ•´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-11-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇÑ°¨¿°ÇÐȸ•´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-11-02
±³À°ÀÏÀÚ : 2023-11-02
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ¿ùµå(¼­¿ïÀá½Ç)

±³À°ÁÖÁ¦ : 2023 ´ëÇÑ°¨¿°ÇÐȸ•´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ°¨¿°ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°¨¿°ÇÐȸ
¿¬¶ôó : 02-2055-1441  

À̸ÞÀÏ : ksinfect@ksid.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ¿¹¹æÀÇÇÐ, ¹Ì»ý¹°ÇÐ, ±â»ýÃæÇÐ

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 140,000¿ø  

ºñ°í »çÀüµî·Ï Àü¹®ÀÇ,±âŸ-(Á¤È¸¿ø)Àü¹®ÀÇ,±âŸ100,000/Àü°øÀÇ60,000/´ëÇлý40,000(ºñȸ¿ø)Àü¹®ÀÇ,±âŸ120,000/Àü°øÀÇ80,000/´ëÇлý50,000ÇöÀåµî·ÏÀü¹®ÀÇ,±âŸ-Àü¹®ÀÇ,±âŸ140,000/Àü°øÀÇ100,000/´ëÇлý70,000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 08:00~08:50 Áõ·Ê1 3ÀÏÀü ¹ß»ýÇÑ º¹ÅëÀ¸·Î ³»¿øÇÑ 64¼¼ ³²ÀÚ È¯ÀÚ ±èÈñ¼º(ÃæºÏ´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 08:00~08:50 Áõ·Ê2 ÀÎÈÄÅëÀ» ÁÖ¼Ò·Î ³»¿øÇÑ 27¼¼ ¿©ÀÚ Á¤ÀºÁÖ(ÇѸ²´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 08:00~08:50 Áõ·Ê3 Ç÷û °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º(CMV) Áõ°¡¸¦ ÁÖ¼Ò·Î ³»¿øÇÑ 59¼¼ ¿©ÀÚ È¯ÀÚ ³ë´öÈñ(°¡Å縯´ë)

±âŸ 11¿ù 02ÀÏ ±×·£µåº¼·ë 08:50~08:55 °³È¸»ç ()

±âŸ 11¿ù 02ÀÏ ±×·£µåº¼·ë 08:55~09:00 Ãà»ç ()

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 09:00~09:20 Minilecture 1. Antimicrobial resistance/Infection control Á¤µÎ·Ã(¼º±Õ°ü´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 09:20~09:40 Minilecture 2. Sepsis/biomarker of infectious diseases ¹Ú´ë¿ø(°í·Á´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 09:40~09:52 Effectiveness and Immunogenicity of MMR Vaccine against SARS-CoV-2 among Healthcare Workers ¼®Çý¸®(°í·Á´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 09:52~10:04 Clinical Characteristics and Outcome of Post COVID-19 Lung Conditions in patients with lymphoma È«ÇÑÅÍ(°¡Å縯´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 10:04~10:16 Ä«¹ÙÆä³Û ³»¼º ´ëÀå±Õ°ú Æó·Å¸·´ë±ÕÀ» °¨¿°½ÃÅ°´Â ¿ë±Õ¼º ¹ÚÅ׸®¿ÀÆÄÁöÀÇ Æ¯¼ººÐ¼® ¹Ú¼º¿ë(±¹¸³º¸°Ç¿¬±¸¿ø)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 10:16~10:28 ¼ö¼ú ¿¹¹æÀû Ç×»ýÁ¦ »ç¿ë ÀûÁ¤¼º Æò°¡ µî±Þ¿¡ µû¸¥ Ç×»ýÁ¦ »ç¿ë ÆÐÅÏÀÇ Â÷ÀÌ À±Ãʼ®(ÇѾç´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 10:28~10:40 Antifungal susceptibility and phylogenetic analysis of clinical and agricultural Fusarium isolates from Korea ³ë´öÈñ(°¡Å縯´ë)

ÈÞ½Ä 11¿ù 02ÀÏ ±×·£µåº¼·ë 10:40~11:00 Coffee break ()

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 11:00~11:30 Literature review ¼¼±Õ,Áø±Õ ÃÖÆò±Õ(¼­¿ï´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 11:30~12:00 Literature review ¹ÙÀÌ·¯½º, ¹é½Å ±èÀ±Á¤(°¡Å縯´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 12:00~13:00 Long-term safety of ART : The Undiscovered Country Áø¹ü½Ä(±¹¸³Áß¾ÓÀÇ·á¿ø)

±âŸ 11¿ù 02ÀÏ ±×·£µåº¼·ë 13:00~13:30 ±¹¸³Áß¾Ó°¨¿°º´º´¿ø °Ç¸³ ¹× ¿î¿µ °èȹ ÁÖ¿µ¼ö(±¹¸³Áß¾ÓÀÇ·á¿ø)

Åä·Ð 11¿ù 02ÀÏ ±×·£µåº¼·ë 13:30~14:00 ÆгΠÅäÀÇ(30ºÐ) À̵¿°Ç ¿Ü 4¸í(°¡Å縯´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 14:00~14:40 Experience from the RECOVERY trial Leon Peto(University of Oxford, UK)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 14:40~15:20 Randomized, Placebo Control Trials in COVID-19: Lessons from ACTT John Beigel(National Institute of Allergy and Infectious Diseases, US)

ÈÞ½Ä 11¿ù 02ÀÏ ±×·£µåº¼·ë 15:20~15:40 Coffee break ()

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 15:40~15:52 CTX-M-15Çü Extended-spectrum ¥â-lactamase »ý¼º ´ëÀå±ÕÀÇ À¯ÀüÀÚ º¯ÀÌ ¿©ºÎ¿¡ µû¸¥ ¼¼±ÕÇÐÀû Ư¡ ºÐ¼® ±ÇÈñÁ¤(ÇѾç´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 15:52~16:04 Association of smoking and sepsis incidence: A Nationwide Population-Based Study ÀÌÀºÈ­(¿¬¼¼´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 16:04~16:16 Intra-host evolution and neutralizing antibody response in persistent SARS-CoV-2 infection receiving B cell depleting treatment ¾È»ó¹Î(¿¬¼¼´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 16:16~16:28 ¾Æ½Ã³×Åä¹ÚÅÍ ¹Ù¿ì¸¶´Ï ±ÕÇ÷Áõ ȯÀÚ¿¡¼­ Á¶±â »ç¸Á°ú °ü·ÃµÈ ¹Ì»ý¹°ÇÐÀû Ư¡ ºÐ¼® ÀÌÂù¹Ì(¼­¿ï´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 16:28~16:40 Obesity paradox does not apply to young adult patients with sepsis: Analysis of MIMIC-IV database. ÀÌ¿ë¼·(¿¬¼¼´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 16:40~17:10 New antimicrobials for resistant bacteria ¹èÀαÔ(°æ»ó´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 17:10~17:40 New antivirals and monoclonal antibodies for viral infections ±è¼ºÇÑ(¿ï»ê´ë)

±³À°½Ã°£ 11¿ù 02ÀÏ ±×·£µåº¼·ë 17:40~18:10 New antifungal agents in development for invasive fungal diseases ¾ÈÁø¿µ(¿¬¼¼´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇÑ°¨¿°ÇÐȸ•´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-11-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â Ãë¾àÁö¿ª ÀÀ±ÞÀÇ·áÁ¾»çÀÚ(ÀÇ»ç) ±³À°(2ÀÏÂ÷) : 2023-11-02
´ÙÀ½±Û ´ëÇÑ¿Ü°úÇÐȸ Annual Congress of KSS(Korean Surgical Society) 2023 (75Â÷ Çмú´ëȸ) 1ÀÏÂ÷ : 2023-11-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 81 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 48 2024-06-18
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 70 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 12 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 78 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 54 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 42 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 39 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 66 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 51 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 47 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 65 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 29 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 25 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 23 2024-06-18
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷